Okay, here’s a breakdown of the key information from the provided text, organized for clarity. I’ll focus on the main points regarding pneumococcal vaccination, notably within minority populations, and the study’s approach.
1. key Takeaway: Pharmacists’ Role & Importance of Targeted Education
* Pharmacists are crucial: The study highlights pharmacists as highly trusted and accessible healthcare professionals, especially within minority communities.
* Tailored Counseling Needed: Pharmacists should use the study’s insights to better counsel and educate patients at highest risk of severe pneumococcal disease and those least likely to get vaccinated.
2. Pneumococcal Disease & Type 2 Diabetes (T2D) in Minority Populations
* Disproportionate Impact: T2D is significantly more prevalent in non-Hispanic Black adults (12.1% rate) compared to White adults (6.9%).
* Increased Risk: Black adults with T2D face a higher risk of serious vascular complications, infectious diseases (including pneumococcal disease), and worsened outcomes.
* Vaccination is Recommended: Pneumococcal vaccination is highly effective for individuals with T2D, and multiple doses may be needed over a lifetime.
* Vaccination Gap: Vaccination rates are lower in non-Hispanic Black individuals compared to other racial groups.
3. Barriers to Vaccination in Black Adults with T2D
* Multiple Factors: Low pneumococcal vaccine uptake is linked to:
* Lack of knowledge about vaccine recommendations
* Mistrust in the healthcare system
* Limited access to healthcare
* Social determinants of health
4. Study Approach: Health Belief Model (HBM)
* Framework: The study used the Health Belief Model (HBM) to understand factors influencing pneumococcal vaccination. The HBM focuses on beliefs about health conditions and preventative actions.
* HBM Constructs: The study examined thes key constructs:
* Perceived Susceptibility
* Perceived severity
* Perceived Benefits
* Perceived Barriers
* Self-Efficacy
* Cues to Action
* Modifying Factors
* Survey Details:
* 57 items across 6 sections
* Sections covered: knowledge, HBM beliefs, mistrust, diabetes characteristics, demographics, and factors affecting vaccination.
* Validated by 5 experts and piloted with 6 non-Hispanic adults with T2D.
5. Participant Characteristics
* Sample Size: 330 participants completed the questionnaire.
* Diabetes Profile:
* Diagnosis > 5 years: 46.4%
* 1-2 diabetes complications: 54.6%
* Treated with oral medications: 40.9%
* Moderate diabetes control: 49.7%
* At least 1 annual health visit: 97.0%
* Knowledge: Knowledge of pneumococcal disease and vaccines was above average. General vaccine beliefs were slightly favorable.
In essence, the study aims to identify the specific beliefs and factors within the Black adult T2D population that influence their decision to get vaccinated against pneumococcal disease, with the ultimate goal of improving vaccination rates and reducing health disparities.
